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Roles in the Protein Ubiquitination 
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Abstract
Protein ubiquitination is an essential cellular process that maintains protein 
homeostasis, regulates protein, and cell functions, and removes aggregated and 
misfolded protein. Disruption in function of any of the protein components of the 
ubiquitination pathway is associated with human diseases including cancers. An 
important member in the ubiquitination cascade is the very large E3 ligase family that 
directs substrate modification. The RING-type E3 ligases possess a cysteine/histidine-
rich zinc-binding RING domain that confers ligase functionality. RING domains 
adopt a canonical ββα-fold. TRIM proteins represent a novel class of RING-type E3 
ligase. TRIM proteins consist of an N-terminal RING domain followed by one or two 
B-box domains. The two types of B-box domains play essential roles in protein ubiqui-
tination by contributing to substrate targeting, ligase activity enhancement, and 
redundancy of ligase activity. This review presents a general background of the B-box 
domains, a structural and functional comparison with RING domains, and a sum-
mary of recent work demonstrating their role in proteolysis. We discuss new findings 
that reveal B-box domains which are ubiquitous and are found in non-TRIM plant 
proteins without the adjacent RING domain, indicating that B-boxes are members of 
RING-class E3 ligases.
Keywords: zinc-finger, ubiquitination, E4 ligases, MID1, TRIM, BBX
1. Introduction
Protein ubiquitination is an essential cellular process that maintains protein 
homeostasis (proteostasis) and removes aggregated and misfolded protein that 
could recruit other proteins away from their normal cellular functions. It serves to 
regulate protein and cellular functions. Dysregulation of any of the protein compo-
nent usually result in human diseases including cancers and birth defects. As such, 
the focus on protein ubiquitination has grown significantly in the past 2 decades, 
leading to extensive knowledge and new insights. A member of the ubiquitination 
cascade that has received considerable attention involves the large and growing 
family of E3 ligases. This family directs the last step in the reaction cascade by 
facilitating the ubiquitination of protein substrates. It is generally accepted that each 
E3 ligase has a specific or group of substrates (Figure 1).
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There are several subgroups of E3 ligases, with the largest consisting of proteins 
with a RING domain that confer ligase functionality. The RING E3 ligase domains 
are cysteine- and histidine-rich sequences that bind two zinc ions in a unique cross-
brace manner and adopt a canonical ββα-fold (Figure 1). Tripartite motif (TRIM) 
proteins represent a new class of RING E3 ligases. TRIM proteins are characterized 
by their N-terminal RING domain followed by one or two cysteine/histidine-rich 
Figure 1. 
Zinc-binding and structure of RING and B-box domains. A. Cross-brace zinc-binding mechanism by Cys/
His-rich sequences of RING and B-box domains. Unlike other zinc-finger domains in which the zinc ion is 
coordinated by Cys and His ligands in a sequential manner, the cross-brace mechanism involves coordination 
by alternating pairs of ligands. The consensus zinc-binding sequences are different for RING and the B-box 
domains. B. Ribbon drawings of a representative RING (pdb 2hdp) domain and MID1 B-box1 (2ffw) and 
B-box2 (2dq5) domains. The ββα-canonical RING fold consists of a short α-helix and two loops, both of which 
contribute ligands to bind the zinc. Loop1 (L1) is usually less mobile than loop2 (L2). The relative locations 
of the zinc ions (red spheres) are similar among RING domains and the B-box domains. C. The superposition 
of structures of the B-box1 and B-box2 domains shows that the overall structures are similar. The structure is 
rendered to smooth out variation of the loop to simplify the image.
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regions called B-box domains. The two types of B-box domains play important 
roles in protein ubiquitination, contributing to substrate targeting, enhancement of 
ligase activity, and redundancy in ligase activity. This review presents a historical 
background of the B-box domains commonly found in TRIM proteins, a structural 
and functional comparison with RING domains, and a summary of recent work 
demonstrating their role in protein ubiquitination. A brief discussion on the current 
understanding of RING E3 ligases mechanism of function is presented. We also 
discuss findings that reveal B-box domains are found in non-TRIM plant proteins 
without an accompanying RING domain. Finally, we argue that the B-box domains 
represent a new addition to the RING-class E3 ligases with a more versatile role 
than RING E3 ligase, namely they bind substrates, regulate E3 ligase activity of the 
adjacent RING domain, enhance E3 ligase activity of TRIM proteins, and actually 
function as E3 ligases.
2. Background
B-box and RING domains fall under the category of zinc-finger domains, which 
are present in a diverse family of proteins that includes transcription factors, 
ribonucleoproteins, proto-oncoproteins, and E3 ligases [1]. Zinc-finger domains 
or proteins are characterized as having cysteine and histidine residues arranged in 
one of several motifs that are relatively conserved in other proteins [2]. The thiol 
group (S−) of the cysteine and a nitrogen atom of the histidine imidazole side-chain 
tetrahedrally bind a zinc ion [2].
Most zinc-finger proteins typically coordinate either a single zinc ion or two zinc 
ions, depending on the number of cysteine and histidine residues and their position 
within the sequence [3]. A defining property of zinc-finger domains is that zinc 
coordination is required to stabilize the tertiary structure. Loss of zinc coordination 
by a mutation of any of its cysteine or histidine residue results in complete unfold-
ing of the protein structure. Protonation of the cysteine or histidine by decreasing 
the pH of the protein solution will also result in unfolding. For domains that bind 
two zinc ions, disruption of coordination of one zinc ion is usually accompanied by 
the loss of binding of the other zinc ion, causing the domain to become unfolded 
rather than partially folded with one zinc ion [4, 5].
Zinc-finger domains were identified in the mid-1980s within the Xenopus 
nuclear factor 7 (XNF7), first by Aaron Klug [6–8]. The subgroups of A-box and 
B-box cysteine/histidine-region domains were first identified a few years later with 
the Xenopus transcription protein TFIIIA ([9]). The A-box domain precedes the 
B-box region by 20–45 amino acids. Subsequently, other proteins were observed 
to have a similar A-box motif without an accompanying B-box region. The A-box 
regions constitute 60–80 amino acids with a zinc-binding consensus sequence of 
C-X2-C-X[9–39]-C-X[1–3]-H-X[2–3]-C-X2-C-X[4–48]-C-X2-C. This consensus sequence 
reveals eight zinc-binding ligands (cysteines) that can coordinate two zinc ions. 
There are also variations in the zinc ligands as A-box domains are observed to 
have more than one histidine. By the early 1990s, the A-box domain was renamed 
really interesting new gene (RING). The uncreative moniker remains for the B-box 
domain [10].
For the next 2 decades, the number of proteins observed with the RING and B-box 
domain pairs would have increased, with most belonging to TRIM proteins that are 
defined by their N-terminal RING, B-box, and coiled-coil (RBCC) domains [11, 12]. 
This RBCC domain arrangement is conserved and found in all multicellular organ-
isms [12]. In humans, the RBCC domain is observed in a family of over 50 proteins; 
although few have been characterized in detail, their importance is underscored by 
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the fact that some are oncoproteins (e.g., PML, RFP, and TIF1a), while others, when 
mutated, give rise to various congenital abnormalities [13, 14]. Members of this large 
protein family are found to play regulatory roles in a variety of cellular processes, 
including sperm vesicle exocytosis and intracellular release of HIV [15, 16]. The RBCC 
domain arrangement indicates at the very least that TRIM proteins have an overall 
common function. The RBCC proteins can have quite diverse C-terminal domain 
arrangements [17].
Interestingly, many TRIM proteins possess three consecutive cysteine/histidine-
rich regions, the first being the RING domain. The other two domains are referred 
to as B-box1 and B-box2 domains ([18]). While the nomenclatures suggest that the 
two types of B-box domains are homologous, they do not share any discernable 
sequence similarity with each other or with RING domains. A single B-box domain 
in TRIM proteins is always of the type 2 form (B-box2), while TRIMs with two have 
the B-box1 domain preceding the B-box2 domain. The name may have persisted to 
prevent confusion in distinguishing the presence of the two types of B-box domains 
in TRIM proteins. The B-box1 domain is slightly larger (50–60 aa) with a zinc-
binding consensus sequence of C-X2-C-X7–12C-X2-C-X4-C-X2-[C/H]-X3–4-H-X4–9-H 
[C5(C/H)H2]. The B-box2 domains are 35–45 and have a consensus sequence 
of C-X2-H-X7–9-C-X2-[C/D/E]-X4-C-X2-C-X3–6-H-X2–4-[C/H] [CHC(C/D/E)
C2H(C/H)] [4]. Comparison of the consensus sequences of RING and the B-box 
domains reveals two regions in which the number of amino acids between zinc-
binding pairs is different. RING domains have the longest length (X [9-39], X [4-48]) 
following by the B-box1 domain (X7–12,X4–9) and B-box2 domain (X7–9, X3–6).
3. Description of B-box domain structures
Despite their prevalence and location downstream of RING domains in TRIM 
proteins, very little was initially done to characterize the structures and functions of 
B-box domains. We postulate that this might have been so because of difficulties in 
obtaining sufficient quantities of the B-box domains for structural and functional 
studies. Indeed, each type of the B-box domain has proven to be quite challenging 
to express and purify using E. coli. The same can be said for RING domains because 
there are only a few dozen structures solved, and given their uniqueness in defin-
ing substrate specificity, structural comparisons would be important to identify 
differences in mechanism of function and activity. Our experience revealed that the 
B-box and RING domains tend to form inclusion bodies [19]. In identifying condi-
tions to obtain large quantities of these domains, we have established a purification 
protocol that not only works for B-box domains but also for other proteins that are 
prone to forming inclusion bodies [19, 20]. The protocol can extract natively folded 
proteins from inclusion bodies without refolding. Despite some of these initial 
challenges, there are now several structures of both types of B-box domains in the 
protein database.
The first comprehensive structural studies of B-box domains were based on 
the TRIM18/MID1 protein [13, 21]. Human MID1 is required for proper midline 
development during embryogenesis ([22–26]). Mutations of MID1, some of which 
are found within the B-box domains, are associated with X-Linked Opitz G/BBB 
syndrome (XLOS), a congenital disorder characterized by clefts of the lip and pal-
ate, cardiac structural defects, and genital anomalies [14, 27].
The structure of the B-box1 domain (residues Gln87-Pro165) was solved in 2006 
by analyzing multidimensional data acquired by nuclear magnetic resonance (NMR) 
spectroscopy. The B-box1 domain was observed to coordinate two zinc ions in a cross-
brace manner with six cysteine and two histidine residues (Figure 1) [13]. Residues 
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Ala115 to Pro165 form the core of the structure, while the preceding 30 amino acids 
are unstructured and initially included to aid in solubility. The structure consists of 
a two-turn α-helix that is preceded by a long structured loop consisting of two short 
β-strands separated by a type-2 β-turn. Two cysteine residues within the first part 
of the structured lasso-like loop1 coordinate one zinc ion with two other cysteine 
residues located within the first helical turn of the helix. Two cysteine residues that 
are part of the β-turn and two histidine residues, one located at the end of the α-helix 
and the other on the loop2 that follows the helix, coordinate the second zinc ion. The 
overall structure is very similar to the ββα-canonical RING fold (Figure 1).
The structure of MID1 B-box2 domain was solved a year later, using NMR data. 
In contrast to the MID1 B-box1 domain, the MID1 B-box2 consists of seven classical 
cysteine and histidine zinc-binding residues, suggesting that only one zinc might 
be coordinated by four of these residues (Figure 1). Sequence alignment of TRIM 
B-box2 domains reveals that approximately half of B-box2 domains consist of 
aspartate residues and the other half a cysteine residues in the same location. This 
observation suggests that Asp must be a highly conserved change [21] that should 
be performing the same role as the cysteine residue. Indeed, the MID1 B-box2 
domain coordinates two zinc ions in a similar cross-brace manner as the B-box1 
and RING domains. Two histidine, cysteine, and aspartate residues coordinate one 
zinc ion. The carboxylate oxygen of this conserved aspartate side chain participates 
in zinc coordination. The aspartate residue forms the necessary zinc-knuckle 
conformation with a cysteine residue two positions away (CxxD) to tetrahedrally 
coordinate the zinc ion [2, 21]. Although carboxylate groups are involved in bind-
ing catalytic zinc ions, for example, carbonic anhydrase [28–30], or other non-
structural metals, this was the first demonstration in a zinc-finger protein. The 
B-box2 domain adopts a two-turn α-helix, two short β-strands separated by a type-2 
β-turn, and two structured loops adjacent to the helix. Despite a lack of sequence 
similarity, the structures of the two types of B-box domains are remarkably similar 
(Figure 1C). The positions of the two zinc ions are in similar locations, namely near 
the N-terminus of the helix and to the bottom left of the helix (given the specific 
orientation shown in Figure 1B). Importantly, the mechanism of zinc coordination 
(cross-brace) and the ββα-fold are comparable to those of RING domains.
Structures of the B-box1 domain from TRIM19 and the B-box2 domain from 
TRIM1/MID2, TRIM5α, TRIM21, TRIM29, TRIM39, TRIM41, TRIM54, and 
TRIM63/MuRF1 have been solved. All the B-box domain structures are similar. 
Consequently, we conclude that MID1 consists of three consecutive domains with 
RING folds. Thus, the TRIM protein family must represent a new class of E3 RING-
type ligase, consisting of two or three consecutive RING folds.
To identify a possible role of the two adjacent B-box domains, the structure of 
both was determined in their native tandem form (res A110-E214). The two B-box 
domains maintained their original structures and pack against each other with the 
interface formed by residues located on the structured loop-1 near the two antiparal-
lel β-strands. The surface area of the interface is 188 Å2 (17% of the total surface). 
Interestingly, the tandem globular structure is very reminiscent of the intermolecular 
association observed for heterodimeric RING structures, such as the BARD1 and 
BRCA1 domains (12) and the polycomb group protein (Bmi-1) and Ring1B polycomb 
group (14), and the homodimeric RINGs, such as HDM2 [31], RNF4 and 8 [32, 33], 
and cIAP2 [34]. The TRIM19 B-box1 and TRIM54 B-box2 domains were solved as 
symmetric dimers by X-ray crystallography. The structures of RING dimers reveal 
the domains interacting via residues located on and near loop-1. The BRCA1-BARD 
and RNF8 dimers also include adjacent structures, such as helical dimers. The area 
of the interface of the hetero- and homo-RING dimers is approximately 150–200 Å2, 
similar to that observed for the MID1 B-box1,2 heterodimer. In spite of their 
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interactions, it appears that in the case of MID1, unfolding of the B-box1 structure, 
via a mutation of one its zinc-binding residues, had little effects on the structure and 
stability of the B-box2 domain [4]. This observation suggests the possibility that each 
B-box domain could function independently or have redundant E3 ligase function.
The structures of two B-box domains were solved in complex with another 
TRIM domain. The TRIM5α B-box2 was crystallized with its coiled-coil domain, 
which contributes to oligomerization. Binding studies using NMR and dynamic 
light scattering using a TRIM5α proteins with a native and mutant B-box2 domain 
reveal that the B-box2 domain contribute to higher order self-association [35]. 
Given that the B-box2 domain is required for substrate ubiquitination, self-
association may contribute to enhanced E3 ligase activity and substrate targeting 
[36, 37] of the native TRIM5α. The B-box domains of TRIM27 are also determined 
to be crucial for multimerization by possibly helping to orient the coiled-coil 
domain in a way that maintained the multimer interaction [38]. In contrast, the 
B-box2 domain of TRIM21 was crystallized with the N-terminal RING domain, 
and the structure reveals that the B-box2 domain interacts with the RING domain 
on a surface that is important for RING-E2 interaction. In this case, the structure 
suggests that TRIM21 B-box2 may have an autoinhibitory effect, although further 
studies are required. It is possible that the structures of these complexes may be 
affected by protein packing within the crystal lattice. More work needs to be done 
to understand the mechanism of function of these B-box domains, which we 
postulate are now key players in the ubiquitination field.
4. A brief description of ubiquitination and the role of E3 ligases
In order to appreciate the function of RING and B-box domains, a brief sum-
mary of protein ubiquitination is provided. All living organisms employ a fairly 
common mechanism to recycle proteins so as to regulate protein function, pro-
teostasis, and cell cycle. Eukaryotic cells employ protein ubiquitination, a post-
translational modification using the highly stable 76-amino acid ubiquitin protein 
(Ub) [39–41]. Bacteria use prokaryotic ubiquitin-like protein (Pup) in an analogous 
manner [42]. Polyubiquitinated proteins, usually with a chain of at least four-linked 
Ub, are targeted to the proteasome where they are proteolytically cleaved into 
peptides [39, 40, 43]. Ubiquitin chains can form via any of its seven lysine residues 
or combinations of the seven; homogenous chain links, example K48, promote 
protein degradation [44–46], but some have signaling functions [47, 48]. The Ubs 
are cleaved by deubiquitinating enzymes (DUBS) and recycled [49]. Although 
mono- and diubiquitinated proteins are directed to the proteasome [50], there is 
evidence that this level of modification serves a signaling role, in which modified 
proteins can have their functions and cellular location altered. The monoubiquitina-
tion of cytosolic proteins results in translocation to the nucleus to participate in 
DNA repair, transcription regulation, and inflammatory response [39, 51–54].
Ubiquitination involves three classes of enzymes. First, the E1-activating 
enzyme (E1) catalyzes the adenylation of the C-terminal glycine of Ub (Ub~AMP). 
This phosphoester bond undergoes a nucleophilic attack by the sulfhydryl group of 
the active site cysteine residue on the E1. In the next step, the Ub is transferred to 
an active site cysteine residue on a family of E2 conjugating enzymes (E2) to form 
an activated thioester-linked E2~Ub complex [39, 43]. Typically most types of E2 
enzymes require the concerted action of an E3 ligase (E3) to target and facilitate 
substrate ubiquitination [40, 43]. There are several classes of E3 ligases: the homol-
ogous to the E6-AP Carboxyl Terminus (HECT), RING-InBetweenRing-RING 
families, and RING class [39–41, 50, 55]. The HECT and RING-IBR-RING families 
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accept the Ub via a trans-thiolation reaction from the E2 before transferring it to 
the target protein. The RING E3 ligase, which includes the Skp-Cullin-F-box (SCF) 
complex, U-box, and now the B-box, represents the overwhelming majority of E3 
ligases. While the mechanism is unclear, the RING-type ligase binds and places in 
close proximity to the target protein and the E2 enzyme. With the SCF complex, the 
RING domain (aka RBX) recruits the E2~Ub, while another SCF subunit (usu-
ally, the F-box) binds the substrate. In the last reaction, the E2~Ub thioester bond 
undergoes a nucleophilic attack (thiolysis) by a lysine residue of the target protein 
whereby the side-chain amino group forms an isopeptide bond with the C-terminal 
carboxylate group of Ub. Subsequent Ubs can be attached to other lysine residues 
of the substrate, but more commonly observed to form a polyubiquitin chain with 
linkages to one of seven lysine residues of the Ub [39, 40, 43]. Chains can be formed 
with Lys 6, 11, 27, 29, 33 and the N-terminus (M1) amino group, but the two more 
common reported linkages involve Lys48 and Lys63 [44]. We argue that the level or 
amount of polyubiquitination or Ub processivity can be an assessment of the level 
of E3 ligase activity by a RING protein.
Typically, confirmation that a RING domain/protein possesses E3 ligase activity 
is accomplished by performing in vitro autoubiquitination assays consisting of all 
the protein components except the substrate. In most cases, the protein substrate is 
unknown. In these reactions, the proximity of the RING domain with the activated 
Figure 2. 
Expected RING E3 ligase results. Cartoon representation of a Western blot image showing autoubiquitination 
results in no E3 ligase (ln1), a RING-type E3 with “weak” E3 ligase activity forming mono- and sometimes 
(di-ubiquitinated) products, and a RING E3 with stronger activities (ln3). The smearing represents 
polyubiquitinated products with various amounts of Ub on the protein. Substrate ubiquitination will usually 
mirror the results shown.
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E2~Ub complex promotes auto- or self-ubiquitination, suggesting that a RING 
protein is a substrate of its own E3 ligase activity. How autoubiquitination affects 
substrate ubiquitination is a subject of intense studies. A protein mixture with E1, 
E2, E3, Ub, and ATP is incubated, and ubiquitinated E3 is probed by Western blot 
with an antibody against the Ub or the E3 ligase (Figure 2). Protein bands corre-
sponding to a RING domain with covalently attached Ubs typically indicate E3 ligase 
activity [39, 40]. The level of E3 ligase activity can be estimated by the rate and 
amount of autoubiquitinated products observed as a function of assay time [56, 57]. 
Western blot images of various levels of polyubiquitinated products are often indi-
cated with a smearing of high molecular weight products, while a less active enzyme 
is indicated by less smearing or the presence of mono- or di-ubiquitinated products 
(Figure 2). However, it should be noted that even though an E3 ligase catalyzes 
mono- and di-ubiquitination does not mean it is a “weak” ligase; it is wholly possible 
that it has evolved to function at this level, and as noted, mono- and di-ubiquitina-
tion may serve as signaling events [54, 58]. There are lots of questions about how 
and why RING domains exhibit different levels of substrate ubiquitination.
5. Possible mechanism of action of RING E3 ligases
As noted, the mechanism of function of RING E3 ligases is unclear, but con-
siderable progress has been made to provide insights. The structures of several 
E2-RING complexes reveal that the RING domain is positioned ~15 Å from the 
active site and the thioester linkage between the E2 and Ub [59, 60]. Based on these 
structures, it is unclear how the RING domain affects reactivity or electrophilicity 
on the E2~Ub linkage. To gain insights on the role of RING E3 ligases, Klevit and 
co-workers [61, 62] used molecular dynamic and NMR studies to show that the 
bound RING E3 ligase promoted a “closed” E2~Ub conformation, whereby the Ub 
populates one interaction mode with slightly greater frequency. In the absence of 
a bound RING domain, the covalently attached Ub is highly mobile and does not 
favor any specific surface of E2 to interact [62]. There is no fixed or stable structure 
between the Ub and E2 proteins. Promoting the positioning of the Ub to the “back” 
surface of the E2 reduces steric hindrance for nucleophilic attack by the incoming 
lysine residue. In addition, key amino acid interactions at the E2-RING binding 
interface appear to contribute to the activation of the thioester bond. For example, 
residue Gln92 of UbcH5 (Ube2D1), which is located on a helical turn adjacent to 
active site Cys-85, forms a hydrogen bond with an arginine or lysine residue on 
loop-2 of the RING domain. Disruption of this interaction through mutation of 
Gln92 or the arginine severely disrupts the rate of Ub transfer [62, 63]. In fact, the 
rate of thiolysis with free lysine, as the substrate, for either mutant is comparable to 
that of E2~Ub without a bound RING domain. Thus, it is generally accepted, given 
what is known from the various E2-RING interaction studies that the RING domain 
contributes allosterically to electrophilicity of the thioester bond.
6. The B-box domains are new members of the RING E3 ligase
Given that the B-box domains have similar RING folds, it was postulated to 
function similarly. First confirmation that the B-box domains possess E3 ligase 
activity was demonstrated with MID1 [64]. The in vitro assays revealed that each 
type of B-box domain exhibited weak E3 ligase activity. Mono-ubiquitinated 
products were observed. Varying degrees of RING E3 ligases activities have 
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been reported in the literature, but no explanation has been provided; for some 
instances, RING hetero- or homodimerization is necessary. Despite the similar 
overall fold of RING and B-box domains, we postulate that subtle amino acid 
differences and structural variations between RING folds may contribute to 
differences in the levels of activities. Furthermore, it is possible that the cohort E2 
enzyme used may provide a specific level of activity [59]. Most RING E3 ligases are 
confirmed using the common UbcH5a–c (Ube2D1–3) E2 family. For MID1 B-box 
domains, mono-ubiquitination activities were observed with at least 12 different 
E2 enzymes [64]. As noted above, it is possible that the level of activities of the 
B-box domains may be physiological and evolutionarily determined. Below, the 
structures of RING and B-box domains are compared to provide rationales for  
the differences in activities.
Intriguingly, the tandem B-box domains also exhibit weak E3 ligase activity, 
with no greater level of autoubiquitination activity than that observed with the 
B-box1 domain [64]. This is in contrast to hetero- and homodimeric RING dimers, 
which exhibited greater activity than the mono form [32, 33, 65]. The BRCA1-
BARD1 complex, in which BRCA1 (breast cancer 1) heterodimerizes with BARD1 
(BRCA1-associated RING domain), exhibited enhanced activities compared to 
BRCA1 alone; BARD1 does not exhibit ligase activity [65–68]. Enhancements of 
activities were also observed for MDM2/HDX [69], RNF4 [33], inhibitor of apop-
tosis (IAP) proteins [70], BMI1-RING1 [71], and membrane-associated RING-CH 
family of E3 ubiquitin ligases (MARCH1) RING dimers [72], to name a few. The 
mechanism of E3 ligase enhancement by RING dimers or the lack of enhancement 
by the MID1 B-box domains is unclear. However, there are several publications 
that proposed rationales of the role of RING dimers [32, 73], but they will not be 
discussed here.
Despite the MID1 B-box domains not showing strong ligase activity, studies 
with TRIM16 revealed that its B-box domains exhibited greater level of activities. 
There were substantial amount of polyubiquitinated products, as demonstrated by 
the intensity of the smearing observed by Western blot analysis [74]. Both in vivo 
and in vitro ubiquitination assays with constructs containing B-box1 and B-box2 
domain deletions resulted in the loss of the polyubiquitin smearing. TRIM16 is a 
pseudo-TRIM that lacks a RING domain; it is possible that TRIM16 B-box1 and 2 
domains have evolved to possess increased activity in light of the missing RING 
domain. However, results from TRIM16 indicate that TRIM16 can dimerize with 
other TRIM proteins, and it may be that these interactions contribute to in vivo 
increased activity. This observation suggests a more intricate mechanism of action 
for TRIM proteins, namely that they can homo- and heterodimerize, and this can 
affect the levels of E3 ligase activity. Furthermore, recent in vitro and in vivo studies 
with TRIM27/rtf, a protein with RING–B-box2-CC domain, showed that the B-box2 
domain, and not the RING domain, is responsible for substrate binding and ubiqui-
tination [75].
7.  Tandem RING and B-box domains are more active: could it be E4 
ligases?
To understand the role of the B-box domains in the context of being adjacent 
to the RING domains, as they are commonly found in TRIM proteins, autou-
biquitination assays were performed with the MID1 RING domain in tandem 
with B-box1 (RING-B-box1 (RB1)) and both B-box domains (RING–B-box1–B-
box2 (RB1B2)). The goal was to determine whether each domain functions 
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independently or if they have synergistic contribution to justify a possible evo-
lutional reason for their presence in tandem. In the case of RB1, greater amount 
of polyubiquitinated products were observed compared with the results of the 
ubiquitination assay with the RING domain alone [14, 64, 76]. The rate of product 
formation was qualitatively faster. Whereas polyubiquitinated products were 
observed with the MID1 RING domain after 120 minutes, polyubiquitinated 
products were observed within the first 5–10 minutes of the assay with RB1. 
Similarly, the MID1 RB1B2 protein construct exhibited comparably rapid ligase 
activity as the RB1 domain construct. Within experimental error, it was difficult 
to determine whether there was greater or lesser amount of polyubiquitinated 
products. Therefore, it was difficult to identify the contribution of the B-box2 
domain within the RB1B2 construct.
To probe whether the B-box2 domain contributes to ligase activity as part of 
the RB1B2 construct, a C142S mutation was introduced within the B-box1 domain 
(RB1*B2). Cysteine-142 coordinates one of the two zinc ions, and its mutations to 
serine resulted in the loss of coordination of both zinc ions and unfolding of the 
B-box1 domain [4]. By Western blot, the E3 ligase activity of the RB1*B2 protein 
construct was indistinguishable from the RB1B2 construct, indicating that the 
B-box2 domain can compensate for the loss of function of the B-box1 domain. To 
confirm that the B-box2 domain has the same enhancing role as the B-box1 domain, 
an RB1* protein construct was designed, and the activity was observed to be similar 
to that of just the RING domain [64].
These observations indicate that the B-box domains, by some unknown 
mechanism, appear to enhance the E3 ligase functionality of the adjacent RING 
domain. It is wholly possible that the enhancement observed could be that both 
RING and the B-box domains have gained E3 ligase activities, there is some syn-
ergy in activities, or that the B-box domains may function as E4 ligases [77–80]. 
E4 ligases are domains with a RING fold that enhance the ligase activity of RING 
E3 ligases. Possible examples of E4-enhancing ligases are the BARD1 and HDMX 
RING domains. In the mid-2000s, the U-box domain, which adopts a similar ββα-
RING fold but without the coordination of zinc ions ([81]), was initially shown 
to play an E4-enhancing role for RING E3 domains [82]. Subsequently, it was 
concluded that U-box domains can function as E3 ligases and now represent a new 
member of the RING-type E3 ligases with a similar mechanism of action as RING 
domains [61, 83, 84].
The function of the B-box domains of TRIM5α, TRIM25, and TRIM32 is also 
studied [85, 86]. TRIM5α possesses anti-viral/anti-HIV activities [56, 87]. TRIM25 
plays a crucial anti-viral role by ubiquitinating the N-terminal caspase activation 
and recruitment domains (CARDs) of the recognition receptor RIG-I [86, 88]. 
Mutations of TRIM32 are associated with limb-girdle muscular dystrophy type 
2H. TRIM25 consists of RING, B-box1, and B-box2, while TRIM5α and TRIM32 
have the RING and B-box2 domains. TRIM25 possesses both Ub and interferon-
stimulated gene 15 (ISG15)-E3 ligase activities [86, 88]. ISGylation serves more of 
a signaling role, as ISG15-modified proteins have altered functions [89]. For these 
proteins, the B-box domains are required for enhanced activities. Using thiolysis 
assays (nucleophilic attack on the thioester of charged E2~Ub by lysine), the role 
of the B-box domains was assessed for TRIM25 and 32 [86]. The constructs with 
the RING domain alone marginally activated the reaction, but those including the 
B-box domains significantly accelerated thiolysis.
In the case of TRIM5α, autoubiquitination assays with monomeric RING alone 
did not produce polyubiquitinated products/chains. In contrast, the RB2 and 
RB2CC protein constructs showed considerable increases in activities, which were 
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attributed to the presence of the B-box domain. As control, the RB2*CC protein 
construct with a destabilizing B-box2 mutant resulted similar levels of ubiquitina-
tion products as just with the RING domain [36].
In summary, the results from the RB1, RB1B2, RB1*B2, and RB1* autoubiquitina-
tion assays of MID1/TRIM18, TRIM25, and TRIM32 suggest that TRIM proteins 
with RING and two B-box domains have some redundancies in the enhancement 
role of the B-box domains. Furthermore, given that the RING-less TRIM16 tandem 
B-box possesses strong ligase activity adds to the support that the B-box domains 
can possibly have dual roles, functioning as E3 and E4 ligases.
8. The B-box domains are required for substrate polyubiquitination
While the in vitro assays confirmed E3 ligase activities of B-box domains and 
their possible role in E3 ligase enhancement, it is important to resolve whether 
observations of autoubiquitination activities translate to substrate ubiquitination. 
In the case of MID1, there are three known substrates: the catalytic subunit of 
protein phosphatase 2A (PP2Ac) [14, 90], alpha4 [76], and the fused kinase (FK) 
[91]. PP2Ac is part of a heterotrimeric PP2A complex consisting of the scaffold-
ing subunit PP2Aa (PR65) and one of several regulatory subunits (PP2Ab) that 
defines cellular location and substrate specificity. PP2A functions as a master 
switch to control metabolism (review [92]), cell cycle progression (via cdc2 
kinase activation), DNA replication, transcription and translation, cell prolifera-
tion, cytoskeleton dynamics and cell mobility, and apoptosis [93–100]. PP2A is 
considered a tumor suppressor, deactivating oncogenic MEK1 and ERK within 
the RAS-RAF-MEK-ERK/MAP kinase cascade [92, 96, 101]. The alpha4 protein 
[102–106] regulates PP2A within the target of rapamycin (TOR) signaling path-
way that controls transcription, protein synthesis, and cell cycle progression in 
response to nutrients and extracellular stimuli [104, 105, 107–112]. Alpha4 binds 
the PP2Ac and induces a conformational change that keeps PP2Ac in an inactive 
conformation until needed [14, 113, 114]. The fused kinase is a key regulator within 
the Sonic Hedgehog pathway important for cell polarization and body symmetry 
[115]. Specifically, FK is shown to activate Hh- and Ci-dependent transcriptional 
activation in Drosophila Schneider 2 cells.
For all three substrates, full-length MID1 was shown to catalyze their polyubiq-
uitination [14, 76, 91]. The role of the B-box domains for substrate ubiquitination 
was demonstrated for PP2Ac and alpha4 [14, 76]. With just the RING domain, a 
weak band was observed on the Western blot, indicating low amount of mono-
ubiquitinated products [14, 76]. In contrast, polyubiquitinated products were 
observed with the RB1 and RB1B2 protein constructs. The results of the assays with 
the RB1* (C141S) protein construct yielded monoubiquitinated PP2Ac and alpha4 
products, confirming the B-box1 domain is important for substrate targeting and 
polyubiquitination. The RB1*B2 protein construct catalyzed the polyubiquitination 
of PP2Ac but not alpha4. These results indicate a few things: the B-box binding of 
protein substrates is a critical role for polyubiquitination, the B-box2 domain can 
compensate for the unfolded B-box1 domain, and the B-box2 domain can contrib-
ute to some B-box1 redundancies in MID1’s overall E3 ligase activity. The levels of 
ubiquitination of PP2Ac and alpha4 parallel the results observed with the autoubiq-
uitination assays, confirming the various roles of the B-box domains. Similar results 
were observed with TRIM5α TRIM25, TRIM19/PML, and TRIM63.
TRIM5α targets the HIV capsid protein. Deletion of the B-box2 domain affected 
oligomerization state, E3 ligase activity, and substrate ubiquitination [35, 37, 56]. 
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TRIM25 targets RIG-I. In vivo studies with HEK293T cells were performed with 
wild-type TRIM25 and with the B-box domains deleted individually and as a pair. 
Protein constructs consisting of either B-box domain yielded polyubiquitinated 
RIG-I products, supporting key observations with the MID1 protein [88]. TRIM19/
PML is a tumor suppressor protein that is associated with a wide variety of can-
cers. TRIM19 is shown to function as a small ubiquitin-like modifier (SUMO) 
protein E3 ligase targeting MDM2, which functions as a regulator of protein p53. 
Sumoylation affects protein stability and cellular localization and sometimes serves 
as precursor to prime the protein substrate for ubiquitination. The results of in 
vivo and in vitro sumoylation assays revealed that the B-box domains are required 
for MDM2 sumoylation. Similarly, mutations destabilizing of the B-box2 domain 
of TRIM28/KAP-1 completely eliminated KRAB domain binding, demonstrat-
ing that the B-box2 domain is important for binding and targeting of the KRAB 
[116]. TRIM63/MuRF1 is found in striated muscle and observed to be upregulated 
with muscle atrophy. The muscle-type creatine kinase (M-CK) is one substrate 
of TRIM63 and co-precipitated with TRIM63 only with an intact B-box2 domain 
[117]. Ubiquitination of M-CK required the B-box2 domain. Furthermore, the 
B-box2 domain also contributed to the overall oligomeric TRIM63 structure [118]. 
It is unclear whether B-box2 domain dimerization or oligomerization is a universal 
observation or protein specific. In the case of MID1, there is no evidence that the 
B-box2 domain is dimer (unpublished data).
Finally and importantly, studies with TRIM27/rfp revealed a central role of the 
B-box domain in substrate binding and ubiquitination and subsequent degradation 
[75]. This report was the first demonstration that E3 ligase activity of TRIM27, a 
TRIM protein with a RING domain, is conferred to the B-box domain instead [75]. 
This unique finding has not, to our knowledge, been observed with any other TRIM 
proteins containing both RING and B-box domains.
9. MID1 B-box1 domain E3 ligase activity can be enhanced
As noted, we postulate that RING E3 ligases that exhibit different levels of in vitro 
activities might be due to evolutionary determinants that include subtle differences 
in amino acids and structures between the RING E3 ligases (Figures 3 and 4). 
This idea is supported with the MID1 B-box1 domain in which an XLOS-specific 
mutation, P151L, yielded a B-box1 domain with greater E3 ligase activity [119]. 
Furthermore, the RB1+(P151L) protein construct possesses greater activity than the 
wild-type RB1 protein construct. NMR data revealed that the B-box1 P151L mutant 
is folded. This proline is conserved among many TRIM B-box1 domains, and it 
may be a key determinant for the weaker E3 ligase activity observed. Residue P151 
is located at the end of the helix and beginning of loop2. Residues of loop2 partici-
pate in E2-RING interactions, specifically allowing an arginine or lysine residue to 
hydrogen bond with E2-Gln92, necessary for activation of the thioester bond in the 
case of Ube2D1. For the MID1 B-box1 domain, the rigidity of the backbone property 
of proline-151 positions loop2 differently, which prevents key loop2-E2 interactions 
(Figure 4A) [119]. The P151L mutation is most likely repositioned loop2 for more 
favorable interactions with the E2 (Ube2D1) enzyme used in the assay. In the case 
of TRIM16, there is no proline in the corresponding location, and this maybe the 
reason why it exhibits greater E3 ligase activity than the MID1 B-box1 domain. The 
lower activity of the B-box2 domain cannot be explained because there is no proline 
residue to reorient loop2. However, compared to the RING consensus sequence, 
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loop2 of MID1 B-box2 and several B-box2 domains are significantly shorter, and this 
could limit optimal interactions with the E2 enzyme.
Intriguingly, even though the P151L mutant B-box1 possesses greater activity, 
substrate ubiquitination assays revealed that the mutation disrupts binding and 
targeting of the alpha4 protein. This observation strongly supports our hypothesis 
that RING E3 ligase activities may be a compromise between level of activity and 
substrate binding, as defined evolutionarily. In unpublished work, we have identi-
fied several specific amino acids in RING domains that are important for RING–E2 
interaction but that are not present in B-box1 domains. Introduction of these amino 
acids into the MID1 B-box1 domain resulted in significant increases in auto- 
ubiquitination activity, including polyubiquitination (unpublished).
Figure 3. 
RING and B-box domain comparison. A. Sequence alignments of five representative RING domains and 
five B-box1 and B-box2 domains from TRIM proteins. The amino acids involved the two zinc ions are 
identified in yellow and lines above connecting the corresponding residues consistent with the cross-brace 
mechanism. Some more conserved hydrophobic residues are colored green, while the acidic and basic residues 
are colored red and cyan. B. Surface representation of HDM2 RING and the MID1 B-box1 and B-box2 
domains displaying the surface in same relative orientation for which the E2 enzyme interacts. Hydrophobic 
(green), basic (K, R, blue), acid (E, D, red), and uncharged polar (white) regions are shown. The pattern 
of amino acid type distribution is similar for many of the RING and solved B-box1 and B-box2 structures.
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10. Structural comparison of RING and B-box domains
In light of our findings that the E3 ligase activity of the MID1 B-box1 domain can 
be enhanced, we examine the structures of RING and B-box domains to understand 
if there may be additional features that can rationalize the difference in activities of 
MID1 RING and B-box domains. While it is not feasible to provide detailed analyses of 
all the differences between the various RING and B-box domain structures, we make 
general qualitative comparisons. As noted, the overall structures of RING and B-box 
domains are similar (Figure 1). In the case of the MID1 B-box domain, the position 
and size of loop2 may contribute to their decreased E3 ligase activities (Figure 4A). 
The sequences of a few RING and B-box domain are aligned, and distributions of 
amino acid types on the E2-binding surface on the RING and B-box domains are 
depicted for comparison (Figures 3 and 4). There are some key differences in amino 
Figure 4. 
E2-E3 interactions. A. Ribbon representation of the UbcH5/Ube2D1(green)-cCbl RING (purple) complex 
with the structure of the B-box1 domain (red) superimposed onto the RING domain. In this orientation, loop2 
is positioned away from the E2-RING binding interface. Residues of RING loop2 make important E2-binding 
interaction; similar interactions are not observed with the B-box1 domain. B. Close-up to the E2-binding 
surface of the fancl RING domain; the dashed line separates the surface of the RING and E2 Ube2T (most of 
which is not shown for clarity). Consistent with several E2-RING complexes, the E2 enzymes bind on a fairly 
large hydrophobic surface on one side of the RING domain (Figure 1) with specific electrostatic and hydrogen 
bonding interactions. Green = hydrophobic residues, blue = basic, red = electrostatic, white = uncharged polar, 
and red-sphere = zinc ions.
15
Zinc-Binding B-Box Domains with RING Folds Serve Critical Roles in the Protein…
DOI: http://dx.doi.org/10.5772/intechopen.85895
acids between the RING and B-box domains that may also contribute to differences 
in the level of activity. However, those will not be discussed in detail here. The exact 
mechanism of E2-Bbox binding has not been characterized, and therefore, for the 
following discussion, we make the assumption that the B-box domains interact with 
the E2 enzyme in a similar manner as RING domains. The different types of residues 
(hydrophobic [green], acidic [red], basic [blue], and uncharged polar [gray]) are 
displayed. We used the HDM2 and human Fanconi anemia (fancl) RING domains 
[31, 120]. On the E2-binding surfaces, both RING domains (Figures 3 and 4) show 
predominantly hydrophobic residues. With the structure of the HDM2 RING domain 
(PDB 2hdp), there is also a large adjacent basic patch on the outer surface of the helix, 
but its role in E2 binding is not clear. There is also a basic residue on loop2 and a small 
acidic patch toward the top of the structure, and these participate in Ube2D2 E2 bind-
ing. For the fancl RING domain, the large hydrophobic patch is located in same region, 
but there are no large charged surfaces. Evaluation of fancl-RING-Ube2T complex 
(PDB 4ccg) reveals that the E2 enzyme interacts predominantly with the hydrophobic 
region of the RING domain (Figure 4B) [120]. Structures of other RING-E2 com-
plexes reveal similar types of interactions.
In contrast, the hydrophobic patches on the MID1 B-box1 and B-box2 structures 
are smaller and not as contiguous as those observed with the HDM2 and Fancl 
RING structures (Figure 3). There are more charged residues on the surface. 
The PML/TRIM19 B-box1 domain (PDB 2mvw) [121] has more polar residues 
distributed instead of hydrophobic residues. Two smaller hydrophobic patches are 
observed on opposite sides. The distribution of residues for the TRIM5α B-box2 
domain (PDB 2ecv) is very similar to that of the MID1 B-box1 structure. These 
comparisons reveal that there are differences in amino acid types at the canonical 
E2-binding site that might influence the mechanism of interactions between RING 
and B-box domains with their cognate E2 enzymes and hence the level of activity.
Interestingly, the structure of fancl RING domain with Ube2T E2 reveals that 
Ube2T does not have a corresponding Gln92 residue to form a hydrogen bond with 
a basic residue on loop2 of the RING domain, which is present is several RING and 
U-box domains. Instead, the complementary positions consist of hydrophobic resi-
dues, suggesting that allosteric effects of RING binding might be transmitted via 
hydrophobic interactions. In contrast, the HDM2 RING domain has an arginine that 
can form a hydrogen bond with Gln92 of the Ube2D2/UbcH5 E2 enzyme. This inter-
action is important for allosteric effects to influence cleavage of the thioester bond. 
It is possible that these subtle differences in binding mechanisms might provide a 
rationale for differences in the level of E3 ligase activities observed for RING-type 
E3 ligases. Differences in activity may also be due to mismatch in cognate E2-RING 
partners with in vitro ubiquitination assays. For example, some RING and B-box 
E3 ligases may possess sumoylation and ISGylation activities and, therefore, prefer 
different E2 conjugating enzymes.
11. B-box2 domain may additionally possess a regulatory role
In addition to the above noted roles of the B-box domains, it has been suggested 
that the presence of MID1 B-box2 domain impacts the binding efficiency of the 
B-box1 domain to alpha4. Binding studies with the MID1 and alpha4 proteins revealed 
tightest binding with a RB1 construct and reduction in binding with RB1B2 and larger 
MID1 constructs [90]. The apparent reduction in RB1-alpha4 binding may due to 
the B-box2 domain binding in an overlapping site with alpha4 [122]. Interestingly, 
we saw a reduction of the band intensities of the polyubiquitinated products of both 
auto- and alpha4-ubiquitinations with RB1B2 [76], indicating that B-box2 domain is 
Ubiquitin Proteasome System - Current Insights into Mechanism Cellular Regulation and Disease
16
regulating the alpha4 interaction. On the other hand, it is possible that the decrease is 
due to the two B-box domains affecting the RB1B2 interaction with the E2 enzyme.
Another TRIM protein for which the B-box2 domain has been ascribed a possible 
regulatory function is TRIM21, which is involved in immune signaling and is found 
in almost all cell types and tissues in mammals. In contrast to MID1, the TRIM21 
RING domain exhibited greater ligase activity than the RB2 protein construct [123]. 
The result is confirmed by the E2~Ub thiolysis assays: the rate of Ub discharge was 
greater with the RING than with the RB2 domain construct. NMR experiments 
confirmed that the RING and B-box2 domains interact via the surface important for 
self-oligomerization [124].
12. The role of B-box domains in RINGless-TRIM proteins
There are currently six characterized human TRIM proteins that lack the 
N-terminal RING domain: TRIM14, TRIM16 (EBBP), TRIM20 (PYRIN/MEFV), 
TRIM29 (ATDC), TRIM44 (DIPB), and TRIM66. RINGless TRIM proteins are 
found in Drosophila melanogaster (Brat, Wech/Dappled) and C. elegans (LIN-41), 
but the functions of these proteins are not characterized. A detailed list of all cur-
rent TRIM, RINGless TRIM, and BBX proteins are shown in Figure 5.
TRIM16 is a transcriptional regulator involved in regulating neuroblastoma cell 
growth, migration, and tumorigenicity [74]. Apparently, it can function as E3 ligase 
via both homodimerization and heterodimerization with TRIM18, TRIM19, and 
TRIM24 [125]. The tandem B-box domains are capable of very weak homodimerizing 
interactions in the absence of the coiled-coil domain. In vitro ubiquitination assay 
with TRIM16 consisting of domain deletions confirmed that the B-box domains 
confer E3 ligase activity [74]. TRIM20 is involved in innate immune response and is 
associated with the autoinflammatory disorder familial Mediterranean fever (FMF), 
characterized by pyogenic arthritis and pyoderma gangrenosum [126]. For TRIM20, 
Figure 5. 
B-box containing TRIM proteins. Protein family distribution of all currently known TRIM and RINGless 
TRIM proteins grouped by the presence of the B-box1 and B-box2 domains. Pseudo-TRIM16 and 66 lack a 
RING domain, and pseudo-TRIM 25 and 69 lack the B-box domains.
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a pyrin domain (PYD) that belongs to the death domain family associated with apop-
tosis and inflammatory responses is in place of the RING domain. TRIM20 targets the 
proline/serine/threonine phosphatase-interacting protein 1 (PSTPIP1) by interac-
tions via the B-box domain. The binding causes the B-box domain to unmask the PYD 
domain, allowing it to interact with downstream binding partners that are important 
for regulating inflammation. Deletion of the B-box domain resulted in constitutively 
active PYD and TRIM20 [127].
Very little is known about the other RINGless-TRIM proteins (Figures 5 and 6). 
TRIM29 is an oncogene that regulates p53 and is overexpressed in many different 
cancers including breast, lung, bladder, and pancreatic [128, 129]. It can form both 
homodimers and heterodimers with TRIM1/MID2, TRIM11, TRIM23, and TRIM27 
[125]. Despite the lack of the RING domain, in vivo studies showed that TRIM27 
maintained E3 ligase activities in response to viral and bacterial infections [130].  
E3 ligase activity of TRIM29 was confirmed through its single B-box2 domain [131]. 
TRIM44 is involved in antiviral and immune response regulation, with some func-
tions linking it to cancer. It can form a heterodimer with TRIM8, TRIM17, TRIM27, 
and TRIM69. Instead of a RING domain, TRIM44 contains a zinc-finger ubiquitin 
protease domain (UBP) that functions as a deubiquitinase [125]. Interestingly, 
TRIM44 is the only known deubiquitinase among the TRIM protein family [132, 133]. 
TRIM14 is involved in antiviral innate immune response [134, 135]. TRIM66 is 
correlated with the proliferation, invasion, and migration of non-small cell lung 
cancer [136]. TRIM66 possesses a PHD zinc-finger domain that preceded the B-box 
domains. The PHD domain is shown to coordinate two zinc ions and adopts RING 
fold, but its function as an E4 ligase is not clear.
While the mechanism of action is not clear, it is possible that RINGless-TRIM 
proteins function through homo- or heterodimerization via at least one of its B-box 
domains. Self-association/oligomerization through the B-box domains is shown to 
contribute to E3 ligase activity possible via an apparent localized concentration effect.
Figure 6. 
B-box containing non-TRIM proteins. Protein family distribution of all currently known non-TRIM proteins 
arranged by the presence of the B-box1 and B-box2 domains. These proteins are generally termed BBX (B-box) 
and COL (Constans-like) and are found in plants. There are nine non-BBX non-TRIM proteins that contain 
RING and B-box domains but lack the coiled-coil domain required for TRIM definition; these are not found in 
plants.
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13. B-box domains are found in plants
While the majority of B-box domains are found in mammals, recent publications 
have identified 32 B-box proteins (known as BBX proteins) in Arabidopsis, rice, 
and more than a dozen other plants species [137]. These non-TRIM proteins do not 
possess a RING domain, and the B-box domains are usually found at the N-terminus 
(Figure 6). The conservation of BBX proteins in multiple plant species suggests that 
these proteins play important roles in plant physiology similar to TRIM proteins 
in mammals [138]. The parallels of TRIM and BBX proteins regarding the B-box 
domains conferring E3 ligase activity suggest conservation of function across mul-
tiple kingdoms. Like TRIM proteins, there is a mixture of BBX proteins that consists 
of either a single or tandem B-box domains. Of the 32 BBX proteins, 21 of them 
have tandem B-box domains, in the same order observed in RING-less TRIM pro-
teins. In rice (Oryza sativa), more than half of its 30 known BBX proteins contain 
two B-box domains [139]. The BBX proteins do not contain a coiled-coil domain but 
shown to interact with proteins that contain a coiled-coil domain to create the TRIM 
equivalent of a RBCC motif (see review [140]). Studies of BBX proteins containing 
tandem B-box domains revealed that only one of the B-box domains is essential for 
maintaining biological activity in plants, supporting redundancy observed with 
several TRIM proteins [141].
Defining specific functions to the B-box domains of BBX proteins is lacking, prob-
ably because of their recent realization in plants. Without specifics, a large number 
of these BBX proteins are postulated to be involved in the ubiquitination pathway. 
Several BBX proteins are shown to interact with an Arabidopsis RING E3 ligase called 
constitutive photomorphogenic-1 (COP1) through interactions with the B-box 
domain, during the dark cycle of plants (see review [140]), but it is unclear whether 
this association is as an E4 ligase to COP1, as a substrate or something else. Similar to 
TRIM B-box domains, the BBX B-box domains play important roles in protein-protein 
interactions, whether directly or indirectly [140]. They can form heterodimers  
and facilitate transcriptional regulation. For example, BBX21, BBX22, BBX24, and  
BBX25 interact with a COP1-associated protein called HY5. The BBX21 and BBX22 
activated HY5 [142], while BBX24 and BBX25 repressed its activity [143, 144].
14. Summary
While it is clear that there is still much to be learned about TRIM proteins and 
their E3 ligase activity, there has been a great push toward better understanding of 
the role of the B-box domains over the past decade. Although the RING domain has 
received much of the spotlight, it is now clear that the B-box domains are integral 
for substrate binding/targeting, protein ubiquitination, and enhancement or 
activation of the ligase activity of TRIM and BBX protein families. B-box domains 
have diverse roles that include protein-protein interactions, substrate ubiquitina-
tion and sumoylation, and transcriptional regulation. What is not clear is whether 
B-box domain really served as E4-enhancing ligase to enhance the ligase activity 
of the RING domains, as observed in dimer RING E3 ligases, or whether they 
synergistically gain activity alongside the RING domains. Their role in contributing 
to oligomerization for some TRIM and BBX proteins to account for enhanced E3 
ligase activity may be due to an apparent increase in the localized concentration of 
the TRIM or BBX protein. However, more studies are needed. Progress will require 
multifaceted approaches involving structure determination, protein-protein bind-
ing studies, and functional assays. Nonetheless, we hope that sufficient evidence 
have been provided, including those of TRIM18/MID1 and TRIM27, demonstrating 
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that B-box domains are and should be considered E3 ligases and not as a supporting 
player to RING domains.
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